BioSpace News Archive

Axcella, a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators to pioneer a new approach for treating complex diseases and improving health, announced that President and CEO Bill Hinshaw will be presenting at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on January 16, 2020 at 8:30 a.m. PT.

Abionic SA, Swiss Medtech firm based in Lausanne, is initiating a pivotal clinical trial in the US for an innovative point-of-care diagnostic method for sepsis to validate the results of a first trial that took place in Europe in 2019, proving the suitability of Abionic’s sepsis test on the abioSCOPE® device to identify sepsis.

enGene Inc., the biotechnology company developing rationally designed gene therapies targeted to mucosal tissues through its proprietary non-viral vector DDX® platform, today announced the appointments of Sharon Tan as Vice President and Head of Program Management, and Lance Dieter as Vice President of CMC and Head of Manufacturing,

Selexis SA, a JSR Life Sciences Company, today announced the promotion of Yemi Onakunle, PhD, MBA, to the position of chief business officer.

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the Indigo® Aspiration System.

Project funded through CQDM Quantum Leap program with support from Merck will explore potential of Fusion’s ONETest to improve diagnosis of respiratory tract infections

Expertise Sharpens Dario’s Focus on Execution and Expansion within the U.S. B2B Channel

Rigel Pharmaceuticals, Inc. announced that Raul Rodriguez, the company’s president and CEO, is scheduled to present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 7:30am PT in San Francisco, CA..

Zai Lab Limited and Novocure announced that the first patient has been enrolled in a phase 2 pilot clinical trial evaluating the safety and efficacy of Tumor Treating Fields in combination with chemotherapy as a first-line treatment in patients with gastric adenocarcinoma.

Osceola Capital, a lower middle-market private equity firm focused on services businesses, announced the acquisition of Healthcents, Inc., a leading provider of medical reimbursement and related services.